Basics of medical therapy—systemic medication, other treatments, monitoring and scoring systems


Medical treatments for skin disease are increasingly focussed on systemic therapy, especially in secondary care. Biologic drugs are being developed to target specific pathways in the pathogenetic mechanisms of several skin diseases. Biologics are discussed in Chapter 61 .

When to select systemic therapy

Systemic treatments are used when topical treatment is ineffective, or for serious skin diseases and infections when a topical approach would be inappropriate. Details of the main classes of systemic drugs used for skin disease are summarised in Table 13.1 .

Table 13.1
An overview of systemic therapy
Group Drug Indications
Corticosteroids Prednisolone usually Bullous disorders, connective tissue disease, vasculitis
Cytotoxics Methotrexate Psoriasis, sarcoidosis, eczema
Hydroxycarbamide Psoriasis
Biologics Etanercept, infliximab, adalimumab, ustekinumab and many others Psoriasis and atopic eczema unresponsive to other systemic agents, off-licence use in other diseases (p. 133)
Immunosuppressants Ciclosporin Psoriasis, atopic eczema, pyoderma gangrenosum
Gold Bullous disorders, lupus erythematosus
Azathioprine, mycophenolate mofetil Bullous disorders, chronic actinic dermatitis, atopic eczema
Retinoids Acitretin Psoriasis, other keratinization disorders
Isotretinoin Acne
Alitretinoin Hand dermatitis
Antifungals Griseofulvin, terbinafine Fungal infection
Ketoconazole Fungal infection ( Candida albicans too)
Itraconazole, fluconazole Fungal infection, candidiasis
Antibiotics Various Skin sepsis, acne, rosacea
Antivirals Aciclovir, valaciclovir Herpes simplex, herpes zoster
Famciclovir Herpes zoster, genital herpes simplex
Antihistamines H1 blockers Urticaria, eczema
Antiandrogens Cyproterone acetate Acne (females only)
Antimalarials Hydroxychloroquine Lupus erythematosus, porphyria cutanea tarda
Antileprotic Dapsone Dermatitis herpetiformis, leprosy, vasculitis

Systemic steroids

The major indications for the use of systemic steroids in skin diseases are for severe conditions such as the blistering disorders, pemphigus and pemphigoid, and for severe involvement by vasculitis, systemic lupus erythematosus, sarcoidosis and some other conditions. Increasingly, the use of the rather non-specific immunosuppressive effect of corticosteroids is being supplanted by biologic drugs that have a more targeted effect or a better safety profile.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here